Alzheimer's biomarkers detection on conventional and innovative platforms are reviewed.
Analytical performances in detecting amyloid-β and Tau protein species are reported.
Critical aspects related to inter-laboratory variability of results are discussed.
Emerging synthetic receptors for AD biomarkers detection are presented and compared.
Future outlooks on alternative matrices and AD biomarkers are presented.